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Abstract 
This is a review on the definition of malaria in Nigeria, historical concept and the journey so far. Malaria is a 
mosquito-borne infectious disease of humans and other animals caused by eukaryotic protists (a type of 
microorganism) of the genus Plasmodium. The protists first infect the liver, then act as parasites within red blood 
cells, causing symptoms that typically include fever and headache, in severe cases progressing to coma or death. 
The disease is widespread in tropical and subtropical regions in a broad band around the equator, including much 
of Sub-Saharan Africa, Asia, and the Americas. Five species of Plasmodium can infect and be transmitted by 
humans. Severe disease is largely caused by P. falciparum while the disease caused by P. vivax, P. ovale, and 
P. malariae is generally a milder form that is rarely fatal.  Malaria is prevalent in tropical regions because the 
significant amounts of rainfall, consistently high temperatures and high humidity, along with stagnant waters in 
which mosquito larvae readily mature, provide them with the environment they need for continuous breeding. 
Disease transmission can be reduced by preventing mosquito bites by distribution of mosquito nets and insect 
repellents, or with mosquito-control measures such as spraying insecticides and draining standing water. The 
World Health Organization is working hard to reduce the burden of malaria in Nigeria and Africa as a whole. 
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INTRODUCTION 
Malaria is a life threatening protozoan disease caused by malaria parasites belonging to the genus Plasmodium. 
Malaria parasites infecting humans belong to four species: Plasmodium (P.) falciparum, P. vivax, P. malariae 
and P.ovale. While these  four species do not ordinarily infect animals; there is evidence that Chimpanzees may 
act as a reservoir host for Plasmodium malariae in Africa, providing a possible source of human infection. Arora 
and Arora;(2009). 
LIFE CYCLE: Malaria parasites exhibit a complex life cycle involving alternating cycles of asexual division 
(Schizogony) occuring in man: an intermediate host and sexual development (sporogony) occuring in female 
anopheles mosquito which serves as a definitive host. Cheesbrough (2006), Arora and Arora; (2008) and (Ross, 
1999). 
HUMAN CYCLE: The sporozoites are the infective form of the parasite.They are present in the 
salivary glands of female anopheles mosquito and are injected directly into the blood stream when it bites a man. 
 Primary exoerythrocytic schizogony: After injection, all the sporozoites leave the  blood stream and 
enter into liver parenchyma cells where they undergo development into primary exoerythrocytic schizont. 
Thereafter, the liver cells ruputures and release merozoites into the blood stream Arora and Arora; (2008). 
Erythrocytic schizogony: The liberated merozoites enter the blood stream and invade red blood cells 
where they multiply at the expense of the red cells.They pass through the stages of trophozoites, schizonts and 
merozoites, then the red cell rupture to release the individual merozoites which then infect fresh red blood 
cells.This parasitic multiplication at this phase is responsible for clinical attack of malaria. (Arora and Arora; 
(2008).  
This erythrocytic schizogony maybe continued for a considerable period, but in the course of time the 
infection tend to die out.  Cheesbrough (2006). (Arora and Arora; (2008). 
Gametogony: After the malaria parasites have undergone erythrocytic schizogony for certain period, 
some merozoites develop within red cells into male and female gametocytes known as microgametocytes and 
macrogametocytes respectively. The development occurs in the red blood cells of the capillaries of internal 
organs like spleen and bone marrow. Only mature gametocytes are found in the peripheral blood without causing 
any febrile condition in human host, they are produced for the propagation and continuance of the species. 
Cheesbrough (2006). (Arora and Arora; (2008). 
Secondary exoerythrocytic schizongony: Occurs only in cases of P.vivax and P.ovale,some injected 
sporozoites on entering into hepatopcytes enter into a resting (dormant) stage, called hypnozoites,  before 
undergoing asexual multiplication while others undergo multiplication without delay. After a period of weeks, 
months or years these hypnozoites are reactivated to become secondary exoerythrocytic schizonts and they 
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release merozoites which infect red blood cells producing relapse of malaria. Cheesbrough  (2006), (Arora and 
Arora; (2008).  The relapse is the situation in which the erythrocytic infection is eliminated and a relapse occurs 
later because of a new invasion of the red blood cells from  the liver merozoites. Hypnozoites are not formed in 
case of P. falciparum and P. malariae therefore relapse does not occur in disease caused by these species. On the 
other hand, recrudescence occurs when red blood cell infection is not eliminated by the immune system or by 
therapy and the number in the red blood cells begin to increase again with subsequent clinical symptoms. 
Cheesbrough  (2006), (Arora and Arora; (2008).   
MOSQUITO CYCLE: Sexual cycle starts in the human host itself by the formation of gametocytes that 
are present in the peripheral blood. Both sexual and asexual forms of the parasite are ingested by the female 
anopheles mosquito during its blood meal on infected patient but only the mature sexual forms are capable of 
further development. In the stomach of the mosquito, microgametes are formed from microgametocyte by the 
process of exflagellation. It develops into a macrogamete, its nucleus shifts to the surface where a projection is 
formed. Fertilization occurs when a microgamete penetrates this projection forming the zygote. The zygote 
matures into Ookinete which penetrates the epithelial lining of  mosquito’s stomach and lies between the 
external border of the epithelial cell and peritrophic membrane. Cheesbrough (2006), (Arora and Arora; (2008).   
Here it develops into Oocyst inside which, the sporozoite develops. The Oocyst when fully mature, 
ruptures and releases sporozoites in the body cavity of the mosquito, they accumulate in the salivary ducts and at 
this stage,the mosquito is capable of transmitting infection to man. Arora and Arora; (2008). 
 
HISTORICAL PERSPECTIVES: 
Malaria is an old disease whose name is derived from the Italian (mal-aria) or “bad air” and it was also known as 
Roman fever, ague, marsh fever, periodic fever, paludism Martin (2003). There were numerous, sometimes 
bizarre theories on how malaria was transmitted until 1898 when Dr. Ronald Ross discovered that the female 
Anopheles mosquito was actually responsible for transmitting malaria parasite. This discovery revolutionized 
malaria control, which had hitherto often been haphazard or based purely on treating the patient by killing the 
malaria parasites. (Phillips, 2001) Cheesbrough (2006), (Arora and Arora; (2008).  . 
Malaria probably originated in Africa and accompanied human migration to the Mediterranean shores, 
India and South East Asia. In the past it used to be common in the marshy areas around Rome. As malaria is a 
disease mostly of tropical and subtropical areas, it is particularly prevalent in sub-Saharan Africa, but also 
common throughout other tropical regions of China, India, Southeast Asia , South and Central America. 
Cheesbrough  (2006), (Arora and Arora; (2008).   
In Nigeria, before independence,the colonialists established Government Reservation Areas (GRA) in 
an attempt to build their homes far away from the natives as it was found that the travelling/flying distance of 
these mosquitoes from the breeding grounds was a limiting factor in spreading the parasites. Nigeria’s quest for 
effective control of malaria began well before the WHO global malaria eradication period betweeen 1955 and 
1968 Gilles et al; (2007). From 1955, however, a more focused egalitarian attempt at evolving strategic plans 
and interventions resulted in pre-eradication pilot studies such as the Kankiya District Project and the 
establishment of a division in  Ministry of Health to deal with the mosquito and malaria problem. 
The National Malaria Control Committee (NMCC) was set up in 1975 with the set mandate to reduce 
the malaria burden by 25% . It produced a five year plan of action that terminated in 1980, however, it recorded 
only modest achievements. It took another 8 years before progress was made when a major health system reform 
was carried out in 1988, with the adoption of a Health Policy for the country. Within this Policy, malaria was to 
be eradicated using the concept of Primary Health Care.  The ministry of Health subsequently prepared 
guidelines for malaria control in 1989. Government finally came out with a National Malaria Control Plan of 
Action 1996. Past and present malaria control programmes as well as the most recent Malaria Control 
Programme Plan achieved limited success in eradicating the scourge. In spite of this, the malaria situation has 
steadily worsened and currently it is estimated that malaria accounts for 65 percent of all diseases reported in 
Nigerian health facilities and that 42% of pregnant women are diagnosed with malaria and affects the birth 
weight of infants. Akanbi (2009). 
Moreover,  it is estimated that at least 1 million people die of malaria each year, mostly children under 5 
years of age WHO; (2005). More than 80% of the deaths worldwide occur in sub-Saharan African. (WHO, 2005, 
Afolabi et al., 2001) 
 
CLINICAL FEATURES AND PATHOLOGY 
Rapid multiplication of the parasites result in destruction of the red cells. This causes a short bout of 
shivering,fever, sweating and the loss of healthy red cells which could lead to anaemia. When the next batch of 
parasites are released symptoms reappear. Fairhurst and Wellems; (2009). In addition, it starts with a cold stage 
(rigor) in which the patient shivers and feel cold, even though his temperature is rising. A hot stage follows in 
which the temperature rises to its maximum, headache is severe and there are back and joint pains, vomitting and 
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diarrhoea.The final stage is when the patient perspires, the temperature falls,the headache and other pains are 
relieved and the patient feels exhausted. Splenomegaly occurs in all forms of malaria with repeated attacks 
causing a greatly enlarged spleen, jaundice, coma, fatgiue, alpha and beta thalassemia. Mockenhaupt et al; 
(2004); Buffet et al; (2009). Haemolytic anaemia  and acute renal impairment are  also features of malaria 
Sowunmi; (1996). 
Malaria caused by P. falciparum  which is referred to as falciparum malaria, formerly known as 
subtertian or malignant tertian malaria is the most widespread and pathogenic of the human species with 
untreated infections causing severe disease and death, particularl y in young children, pregnant women and non 
immune adults Miller et al; (1994). 
The Pathogenicity of P.falciparum is mainly due to: The cytoadherence of  P.falciparum parasitized red 
cells,causing the cells to adhere to one another and to the walls of capillaries in the brain, muscle, kidneys and 
elsewhere. Sequestration of parasitized cells in the microcirculation causes congestion, hypoxia, blockage and 
rupturing of small blood vessels. Ho and White (1999). High levels of parasitemia resulting in the activation of 
cytokines and destruction of  red cells; Angulo and Fresno (2002) 
The factors that contribute to the spread and transmission of malaria  depend on the interraction 
between the human host, anopheles vector, malaria parasite and environmental conditions.  Arora and Arora; 
(2009). The pravalence is higher in rainy season than in dry season due to the breeding habitat of mosquitoes 
such as water,ponds, potholes and uncovered ditches Cheesbrough; (2006). Other factors contributing to the 
persistence of malaria in the country include  resistance of P. falciparum to drugs such as chloroquine and of 
Anopheles mosquitoes to insecticides, impoverished economy, increased urbanization and development of 
epidermics following natural disasters and social unrest Cheesbrough; (2006). Futhermore if red cells of donors 
who recently visited or who have lived in a country where malaria is present are  used, malaria parasites, which 
resist storage at 4OC , may therefore be transmitted to the recipient of infected red cells. Uneke et al; (2006) 
 
PREVENTION AND CONTROL:  
Measures necessary for the prevention and control of malaria include the following:  Measures directed against 
the breeding of mosquito larva such as flushing or draining of breeding sites,clearing vegetation and spraying 
breeding sites with oil or chemicals. Measures directed against mosquito bites such as screening windows and 
doors with fine mosquito netting, bed netting treated with insecticides, wearing protective clothing, use of 
mosquito repellant and insecticides. Preventive and creative measures such as early diagnosis and treatment with 
drugs. 
Health education to the people and the community on malaria control measures. ( Hall, 2006). 
 
THE HEAVY BURDEN OF MALARIA IN AFRICA 
Burden of malaria in Nigeria: Nigeria’s health care system as provided through the public sector is organised in a 
three tiered system. The federal government develops policies and guidelines, providing funding and technical 
support as well as monitoring and evaluating implementation, the 36 states provide the second tier of the system. 
The third tier is at the level of the local government. Although decentralization is a stated goal of the current 
health ministry, the states and the local governments primarily implement policies developed at the federal level. 
Local council health departments are required to establish educational malaria programmes. With the prime 
focus being malaria control. National Malaria Control Programme (2011). In Nigeria, there is an estimated 25%-
30% of  mortality in children under five or an estimated 300,000 deaths each year due to malaria. Carson et 
al;(1998). In April 2004 Nigeria’s Health minister reported that it spent over $1 billon annually in treating 
malaria and that malaria was the cause of one out of three deaths in children and one out of ten deaths of 
pregnant women English et al; (2007). Chloroquine  resistance was cited as a growing problem, owing in part to 
counterfeit drugs Evans et al; (2005) and Ajayi et al., (2003). Also, a director at the World Health Organisation, 
disclosed that residents of Lagos State in Nigeria spend about N1trillion annually on malaria treatment. 
Malaria in africa: More than  1  million children die annually from malaria in Africa Allen et al; (1996), 
a child dies every 30second from malaria in Africa,70% of deaths occur in children <5years of age 
Cheesebrough; (2006), and even in the first 6 months of life. Afolabi et al., (2001). Growing political 
commitment by African leaders for action on malaria was given a boost by the founding of the Roll Back 
Malaria (RBM) global partnership in 1998. Less than two years later African Heads of State and their 
representatives met in Abuja, Nigeria to translate RBM's goal of halving the malaria burden by 2010 into 
tangible political action. The Abuja Declaration endorsed RBM's goal and established a series of interim targets 
for the number of people having access to treatment, protective measures or, in the case of pregnant women, 
receiving intermittent preventive treatment to ensure that progress would be made towards the goal and malaria-
endemic countries and other RBM partners held responsible. Considerable progress has been made since Abuja. 
Almost 20 African countries have reduced or eliminated taxes and tariffs on insecticide-treated nets (ITNs) to 
make them more affordable. More than half the malaria-endemic African countries, representing almost half the 
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population at risk have established Country Strategic Plans (CSPs) to achieve the RBM goal and the targets set 
in Abuja. CSPs are all based on the four technical elements of Roll Back Malaria and the evidence-based 
interventions associated with them prompt access to effective treatment promotion of ITNs and improved vector 
control, prevention and management of malaria in pregnancy and improving the prevention of, and response to, 
malaria epidemics and malaria in complex emergencies. Cheesbrough Monica  (2006), (Arora and Arora; (2008).   
Countries are now working through local partnerships to develop the capacity to fully implement their 
CSPs using ongoing health sector reforms and linkages to other initiatives, such as IMCI (Integrated 
Management of Childhood Illness) and MPS (Making Pregnancy Safer), to improve access to key interventions. 
CSPs have been successful in attracting new resources for malaria control. However, given projected resource 
needs to the year 2010, only 20% of necessary funds will be available locally. African countries, working with 
their partners and donors, must identify and mobilize resources for the remainder. Countries are looking to a 
variety of sources to ensure sustainable financing of their efforts to Roll Back Malaria this includes traditional 
sources of funding, from the national treasury and donor community as well as the exploration of new 
opportunities through debt relief schemes and the newly formed Global Fund to Fight AIDS, TB and Malaria 
WHO: ROLL BACK MALARIA; (2000).  
 
MALARIA BURDEN AND THE ECONOMY 
Malaria limits international trade  and development. The parts of the world that are continously at high risk of 
malaria are predominantly the poorest  Alnwick; (2001). Malaria is the major cause of absenteeism from work 
and school in Africa and reduced productivity, reduction in labour supply, illness and death Klausner and Alonso; 
(2004) 
 
MALARIA  TRANSMISSION  PATTERN 
Malaria transmission and severity of the disease vary greatly from region to region, village to village and even 
from person to person Beales and Gilles; (2002). Mortality rate from malaria is higher in children between the 
ages of 6months and 5 years Maitland et al: (2004), Afolabi et al., (2001). Children below  the ages of 6months 
are protected due to passive immunity acquired from the mother and the fact that fetal haemoglobin does not 
support parasite growth Afolabi et al; (2001). The protection ceases after 6months and the child is vulnerable till 
the age of 5years afterwards immunity is then developed as a result of repeated attacks of malaria. Sharma et al; 
(2004). Up to 70% of individuals living in endemic areas carry the parasite without manifesting the symptom 
(asymptomatic malaria) up to 20% of school age children have been shown to carry sub-microscopic levels of 
the malaria parasites (sub-patent parasitemia) that can only be deteced by polymerase chain reaction (PCR) 
Bottius et al; (1996). 
 
MALARIA CONTROL 
Study shows that rate of transmission of parasite causing malaria differ depending on local factors such as 
rainfall patterns,the proximity of mosquito breeding sites to people  and the type of mosquito species in the area. 
Lehmann et al; (2010). Malaria parasites are endemic in some region, where there are fairly constant number of 
cases throughout the year, while some region have “malaria season” mostly during rainy season. World Malaria 
report; (2008) shows that large and devastating epidemic can occur when the mosquito-borne parasite is 
introduced into areas where people had, had little prior contact with infected parasite and have little or no 
immunity to malaria, or when people with low immunity move into areas where malaria cases are constant. As 
malaria control intensifies, World malaria report; (2008) suggested that it is vital to monitor malaria burden, 
trends and track the coverage and impact of interventions while malaria undoubtedly imposes a major public 
health burden,estimates of the numbers of cases and death have been, for many countries too inaccurate to 
establish firm baseline against which to evaluate the success of control measures. Hoffman et al., (2003), 
Hoffman et al., (2002) and Keiser et al., (2004). Study report of Global Burden of Disease;WHO (2004) shows 
that non immune pregnant women are at high risk of malaria can result in high rate of miscarriage and cause 
over 10% of maternal deaths, severe anaemia and impaired fetal growth. Sickle cell disease, thalassemias and 
other hemoglobinopathies are among the most common genetic disorders of human. Newton and Krishman, 
(1998) Their high prevalence’s in malaria endemic areas are considered to result from balancing selection, in that 
reduced fitness of affected individuals is counter balanced by some mode of protection against malaria Evans et 
al; (2005). Vector control has saved millions of lives worldwide, through indoor residual spraying, 
environmental management to eliminate breeding sites and use of mosquito larvicides. Steketee and Campbell; 
(2010). 
Indoors Resident Spraying (IRS): One of the most effective methods of vector control is indoor residual 
spraying (IRS) In this method the inside wall of houses are sprayed with residual insecticides. When the 
mosquitoes rest on the wall, they absorb the insecticides through their feet Alnwick; (2001). The pesticides either 
kill them immediately or soon afterwards. Its cost, logistical complexity and moderate efficacy make it poorly 
Journal of Biology and Medical Sciences                                                                                                                                          www.iiste.org 
ISSN 2409-5117     An International Peer-reviewed Journal 
Vol.3, 2015 
 
37 
suited for controlling malaria in rural areas of sub Saharan Africa. 
 
INSECTICIDE TREATED NETS 
In another method of control, a person sleeps under insecticide treated nets [ITNS]. The ITN works not only by 
creating a barrier between the mosquito and the intended meal, but also by killing the mosquito if it lands on the 
net Grover et al; (2006). Reduction of human-vector contact through insecticide-treated bed nets is better suited 
for malaria control in Africa, it enjoys greater community acceptance and is as efficacious as indoor residual 
spraying.  Although they are inexpensive and effective, fewer than 2% of Africans sleep under them WHO; 
(2000). Massive campaigns to increase their use are required as a matter of urgency especially in rural Nigeria. 
Countries around the world use other methods of vector control with varying degrees of success. These methods 
include larviciding, the removal of breeding grounds by drying up wet lands or ensuring that pools of standing 
water are drained or by using biological controls such as fish that eats mosquito larvae. Walker (2002). The 
success of these controls depends highly on the type of vector and its breeding habitat, the geography of the area 
and the socioeconomic status of the population at risk.  
Other strategies include: Intermittent preventive treatment in infants and pregnant women using existing 
drugs to protect them from the worst effects of the disease. Infants receive an antimalarial three times during the 
first year of life at the time of routine immunisation, whether or not they have malaria. IPT has the potential to 
become a major tool for malaria control in Africa because it can be delivered through the Expanded Programme 
on Immunisation [EPI], one of the best functioning systems of regular health contact with young children in 
Africa. UNICEF (2003).  
 
LABORATORY DIAGNOSIS OF MALARIA 
MICROSCOPY BASED TESTS 
STAINS: A number of Romanowsky stains like Fields, Giemsa, Wrights and Leishmans are suitable for staining 
the smears. Thick films are ideally stained by the rapid Fields technique or Giemsa stain for screening of 
parasites. The sensitivity of a thick blood film is 5-10 parasites/µl. The blood films stained by Giemsa’s or 
Leishmans stain are useful for specification of parasites and for the stippling of infected red cells and have a 
sensitivity 200parasites/µl. Castelli and Carosi; (1997). 
The exacting needs of the blood smear examination, detection of low levels of parasitemia, sequestered  
parasites of P. falciparum and past infections in aspiring blood donors, ascertaining viability of the detected 
parasites, difficulties  in maintaining the required technical skills are some of the deficiencies with the blood 
smear examination Grobusch et al;(1999). 
Alternative microscopic methods have been tried, including faster methods of preparation, dark field 
microscopy and stains like benzothiocarboxypurine, acridine orange and Rhodamine-123 Keiser et al; (2002). 
Acridine orange has been tried as a direct staining technique with concentration methods such as thick blood film 
or the centrifugal quantitative buffy coat system and with excitation filter in the kawamoto technique Lowe et 
al;(1996). Inability to easily differentiate the plasmodium species, requirements of expensive 
equipment ,supplies and special training as well as the high cost limit the use of these methods Htut et al; (2002). 
Fixed and preserved blood smears of patients for malaria were used for comparative analysis of acridine 
orange and giemsa stains Tarimo et al; (1998). The acridine orange staining method required less time and was 
more sensitive under lower magnification than the giemsa staining method. The acridine orange staining method 
provides an alternative to giemsa for malaria diagnosis in the field and laboratory Kong and Chung; (1995).     
Dip Stick: The WHO said that the development of quality assured rapid diagnostic tests using a dip 
stick and a drop of blood necessitated a policy change. The tests can reliably demonstrate the presence or 
absence of malaria parasites in the blood and can be performed at all levels of the health system, including 
community settings. Rapid diagnostic tests (rdts), dipsticks or test strip bearing monoclonal antibodies directed 
against the target parasite antigens are simple to perform and to interpret. No electricity is required electricity, 
special equipment or training in microscopy They may detect P. falciparum infection even when the parasites are 
sequestrated in the deep vascular compartment and undetectable by microscopic examination of a peripheral 
blood smear Bell; (2004). 
They are, however, more expensive than microscopy can detect antigens produced by gametocytes can 
give positive results in infections where only gametocytes are present. Gametocytes do not cause any febrile 
condition and those of P.falciparum are not affected by schizonticidal drugs. Such positive results can lead to 
erroneous interpretations and unnecessary treatment Arora and Arora; (2009). 
 
Quantitative buffy coat (QBC) test 
This method for identifying the malaria parasites in the peripheral blood was developed by Becton and 
Dickenson inc. Test involves staining of the centrifuged and compressed red cell layer with acridine orange and 
its examination under UV light source. It is fast, easy and more sensitive than the traditional thick smear film 
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examination Arora and Arora; (2009). 
 
TREATMENT                                                                                                     
Drugs:  Different methods of treatment of malaria has been reported previously and new methods of treatments 
are daily coming up due to modern techniques of understanding drugs and the parasited and the parasites mode 
of resistance to these drugs continues daily. (Olowe (2010). Unpublished article.   
Quinine which has been used for more than three centuries is one of the four main alkaloids found in 
the back of cinchona tree, and it’s the only drug which over a long period of time has remained largely effective 
for treating the disease, partly because of undesirable side effects. it is used for treating severe Falciparum 
malaria. Newton and Krishna; (1998).                                       
 Chloroquine: First used in the 1940s shortly after the second world war is a low cost drug but very 
effective for treatment and prophylaxis. It was used in curing all forms of malaria, with few side effects when 
taken in the prescribed dose. Unfortunately most strains of falciparum malaria are now resistant to chloroquine.  
Meerman et al; (2005).                                                                         
Fansidar: It’s a combination drug, each tablet containing Sulphadoxine 500mg and Pyrimethamine 
25mg.    Resistance to Fansidar is now widespread and side effects have been reported Evans et al; (2005). 
Maloprim: is a combination of dapsone and pyrimethamine. Resistance to this drug is now so 
widespread that its use is no longer recommended Murphy et al; (1995). 
Mefloquine (Lariam) was first introduced in 1971 and it is related structurally to quinine. The 
compound was effective against malaria. Its long life meant to serve as a good prophylacatic increasing 
resistance and together with undesirable side effects including acute brain syndrome has resulted in a decline in 
its use, White; (1998). 
Halofantrin: belong to a class called the phenanathrene-methanols. It is an effective antimalarial 
introduced in the 1980s, has a short half life and is therefore not suitable for use as a prophylactic. Unfortunately 
resistant forms are increasingly being reported, and there is some concern about side effects such as 
neuropsychiatric disturbances.  
Artemisinins is derived from a Chinese herbal remedy and covers a group of products. The two most 
widely used are Artesunate and Artemether. A high rate of treatment failures have been reported and it is now 
being combined with mefloquine  and other antimalarials (ACT) for the treatment of falciparum malaria Hall; 
(2006). The artemisinin derivatives are the most rapidly schizonticidal antimalarial drugs known to date though 
do not remain in the blood stream for long. Meshnick et al; (1996). It has relatively good safety profile despite 
initial anxiety following pre-clinical findings and reduction in malaria transmission. 
Factors that govern choice of drugs include parasite species, level of resistance to drugs in location, 
patients general health and medical history and availability of medication. 
 
Vaccine production: Many factors make malaria vaccine development difficult and quite challenging. First the 
size and genetic complexity of the parasite mean that each infection presents thousands of antigens to the human 
immune system. Secondly, the parasite changes through several life stages even while in the human host, 
presenting a different substance of molecules for the immune system to combat at each stage. Playfair and 
Taverne; (1990). Thirdly, the parasite has evolved a series of strategies that allow it to confuse, hide and 
misdirect the human immune system. To develop vaccines and drugs that exploit their vulnerabilities in the 
parasites biology necessitates a complete understanding of the parasite and its complex relationship with its 
human and vector host. This is where unravelling the genetic code of P. falciparum published in 2002 presents a 
ray of hope as this has energised the malaria scientific community and also served to attract a much broader 
range of scientists to join the effort in discovering an effective vaccine. Scientists have brought technologies 
such as gene chips, proteomics and comparative genomics to research, though for now, no extraordinary 
breakthroughs are forthcoming. Malaria vaccine has not been forthcoming for quite sometime, but the rising 
funding levels, promising scientific advances and heightened global awareness of malaria have increased 
commitment to develop an effective malaria vaccine as soon as possible. 
The malaria vaccine trial is the most promising yet. The vaccine is directed against the sporozoites. The 
Path Malaria Vaccine Initiative is very encouraging that among the under two year olds studied, the vaccine was 
about 50% effective against severe malaria. Bejon et al (2008). 
 
Mosquito Modification: Other genetic approaches include modifying mosquitoes to produce offspring that 
cannot transmit disease but this failed because where several species of vector are present, a separate transgenic 
must be created for each one. WHO, (2004; 2005) 
 
Insecticides: Dichlorodiphenyltrichoroethane (DDT), an organochlorine pesticide, became widely used in pest 
control after its discovery in 1972. Fear of it being a potential human carcinogen has limited its use, however, 
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some nations still effectively use DDT formulae control. Ecuador for example has increased its use of DDT since 
1993 and has experienced the largest reduction of malaria rates in the world. Roberts; (1997), Zakai, (2003). 
 
RECOMMENDATIONS 
The use of insect repellent in addition to increasing coverage of long lasting insecticide treated bed nets will 
provide greater protection.  
The current tools for combating malaria such as artemisinin-combination therapy and can result in a 
major reduction in Plasmodium falciparum. 
Control of mosquito, vectors of malaria may be enhanced by newer methods of biocontrol such as 
biopesticides containing a fungus that is pathogenic to mosquitoes hence reducing malaria transmission. 
The effectiveness of an intermittent preventive treatment against malaria in children may be hindered 
by high incidence of malnutrition therefore adequate nutrition will help boost the immune system and may help 
protect children from malaria. 
Existing Programmes such as Expanded Programme on Immunization, one of the best functioning 
systems of regular health contact with young children in Africa should be strengthened by Government. 
The evolvement of vaccines in developed countries against malaria parasites should be welcomed and 
funded by government in Nigeria. 
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